Husak R, Garbe C, Orfanos C E
Department of Dermatology, University Medical Center Benjamin Franklin, Free University of Berlin, Germany.
J Am Acad Dermatol. 1996 Dec;35(6):928-34. doi: 10.1016/s0190-9622(96)90117-6.
Oral hairy leukoplakia (OHL) is a benign hyperplasia of the oral mucosa that is induced by Epstein-Barr virus. It occurs nearly exclusively in men infected with HIV. OHL is a marker of moderate to advanced immunodeficiency and disease progression in patients with HIV infection.
We attempted to determine the clinical characteristics of OHL in a large group of patients infected with HIV and to analyze its relation to immune status and prognosis.
A total of 456 patients with HIV-associated skin disorders were evaluated during the years 1982 through 1992. All patients had an oral examination. CD4+ cell counts were obtained within 3 months of the examination.
OHL was diagnosed in 15.6% of 456 patients. The median age of the patients was 35 years. OHL was found most often on the lateral aspect of the tongue; in one patient the lesion covered the entire dorsal surface of the tongue. Significant immunosuppression was present in the majority of patients at the time of OHL diagnosis (median CD4+ T-lymphocyte count, 235/microliter; median CD4+/CD8+ ratio, 0.3). The median survival time was 20 months in patients with OHL. In patients with a higher CD4 cell count (CD4+ T lymphocyte count, > or = 300/microliter) the diagnosis of OHL was associated with shorter survival times (median survival time, 25 months) compared with other patients with HIV (median survival time, 52 months).
OHL is a frequent finding in patients with HIV and indicates advanced immunosuppression. Even in patients with more than 300/microliter CD4+ T lymphocytes, OHL is associated with a poor prognosis.
口腔毛状白斑(OHL)是由爱泼斯坦-巴尔病毒引起的口腔黏膜良性增生。它几乎仅发生于感染HIV的男性。OHL是HIV感染患者中至重度免疫缺陷及疾病进展的一个标志。
我们试图确定一大组HIV感染患者中OHL的临床特征,并分析其与免疫状态及预后的关系。
在1982年至1992年期间对总共456例HIV相关皮肤疾病患者进行了评估。所有患者均接受了口腔检查。在检查后3个月内获取CD4+细胞计数。
456例患者中有15.6%被诊断为OHL。患者的中位年龄为35岁。OHL最常出现在舌的外侧;有1例患者病变覆盖了整个舌背表面。在大多数OHL诊断时的患者中存在显著的免疫抑制(中位CD4+ T淋巴细胞计数为235/微升;中位CD4+/CDS+比值为0.3)。OHL患者的中位生存时间为20个月。与其他HIV患者(中位生存时间为52个月)相比,CD4细胞计数较高(CD4+ T淋巴细胞计数≥300/微升)的患者中OHL诊断与较短的生存时间相关(中位生存时间为25个月)。
OHL在HIV患者中很常见,表明存在严重的免疫抑制。即使在CD4+ T淋巴细胞超过300/微升的患者中,OHL也与不良预后相关。